The growth for Vertex’s Journavax painkiller is just beginning to ramp up, given the potential size of the nonaddictive drug ...

Recursion uses artificial intelligence to help advance drug discovery, which could be a massive opportunity in healthcare.

Dyne Therapeutics’ stock sees record rally, but one analyst says it could still climb a lot further, after a rival got bought ...

Now, it’s worth noting Stock Advisor’s total average return is 1,033% — a market-crushing outperformance compared to 193 % ...

These companies are investing heavily into their pipelines and the payoff for long-term investors can be substantial.

And I do have several favorite stocks that fit that description. My top growth stock to buy in November is one that I've ...

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the most profitable biotech stocks to buy. Wells Fargo maintained a Buy ...

Biotech stocks have trailed the broader market this year, but more names are starting to show strength as the rally expands ...

Genmab A/S (NASDAQ: GMAB) is one of the most profitable biotech stocks to buy. H.C. Wainwright analyst Ram Selvaraju ...

Shares of Strides Pharma Ltd. surged 10% to a record high of ₹1,025 on Monday, November 3, extending gains for the fourth consecutive session. The stock has rallied 26% in the past four trading days ...

Shares of Corbus Pharmaceuticals slid after the company priced its public offering at $13 a share. The stock declined 24% to $12.49 on Friday. Shares are down 22% in the past 12 months.

As the European market navigates a mixed landscape, with the pan-European STOXX Europe 600 Index recently dipping by 0.67% amid tempered expectations for further ECB rate cuts, investors are keenly ...